Reuters logo
10 months ago
BRIEF-Pharma Mar reports positive results from phase II trial with PM1183 in breast cancer
October 10, 2016 / 6:41 AM / 10 months ago

BRIEF-Pharma Mar reports positive results from phase II trial with PM1183 in breast cancer

1 Min Read

Oct 10 (Reuters) - Pharma Mar SA :

* Reports positive results from phase II trial with lurbinectedin (PM1183) in patients with metastatic breast cancer

* The study met the initial objective for an overall response rate (ORR) in 41 percent of patients Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below